Analytical Data
-
基因名
H1-1
- Application
-
别名
H1 VAR.3Histone H1a ;H1a
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43275
-
表达区间
2-213aa
-
分子量
48.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
H1-1 recombinant protein, derived from the human immune response, plays a significant role in immunological research due to its potential therapeutic applications. This protein is a member of the H1 family, which is known for its involvement in modulating immune responses. The increasing prevalence of autoimmune diseases and the need for targeted therapies have spurred interest in understanding how H1-1 can influence immune cell signaling and function. Research has shown that H1-1 can interact with various immune receptors and cytokines, suggesting its potential to enhance or regulate immune responses. Furthermore, studies indicate that H1-1 may have a role in tumor immunology, making it a candidate for cancer immunotherapy. The recombinant expression of H1-1 facilitates detailed investigations into its biological activities, allowing scientists to explore its mechanisms of action and therapeutic potential. Overall, the study of H1-1 recombinant protein is at the forefront of developing new strategies for treating immune-related disorders, contributing to advancements in biomedicine and therapeutic interventions.
